Best Warren Buffett Stocks To Own Right Now

Introduction: The Seeking Alpha Experiment

Warren Buffett began his investing career with $105,000. Now the man is worth $53.5 billion (according to Forbes) Like every other young hot shot investor, I strive to emulate this man's success. With this being said, I won't be terribly upset if in 60 years I'm not the 4th richest man in the world. I'm a realistic person. I have goals that I'd like to meet for myself and my family that aren't as lofty as Mr. Buffett's current financial status. But, I also believe that if you're going to play the game you ought to play to win. And I'd say that without a doubt, Mr. Buffett has been victorious.

This $105,000 initial starting dollar pool also recently caught my attention for another reason. I currently rent a cottage on a horse farm. Sitting in the barn, the farm's manager, a former farm boy who studied economics and computer science in college and made his fortune in the 1980's and 1990's working in Silicon Valley during the original tech boom and making prudent investment decisions in regards to the early tech stocks, said to me: "It's that first $100,000 that's hard to save; once you get there you'll be right as rain." I respect this man immensely and am grateful that after a decade or so on the tech grind in California he decided to move back east and resume farming. He is hard headed and won't let me win easily. He's a wonderful sounding board for me as my economic education continues. I also believe that this relationship is symbiotic; I think secretly he relishes the sometimes heated market related discussions we have, his days around the farm just wouldn't be the same without them.

Best Warren Buffett Stocks To Own Right Now: BioAmber Inc (BIOA)

BioAmber Inc. (BioAmber), incorporated on October 15, 2008, is a chemical company. The Company manufactures its bio-succinic acid in a facility using a commercial scale 350,000 liter fermenter in Pomacle, France. During the year ended December 31, 2011, the Company produced 487,000 pounds, or 221 metric tons, of bio-succinic acid at this facility. Succinic acid is used to manufacture a range of products used every day, including plastics, food additives and personal care products, and can also be used as a building block for a range of derivative chemicals. The Company produces and sells bio-succinic acid using its process for petroleum-derived succinic acid. It also has additional bio-based products under development with partners including bio-succinic acid derivatives, such as BDO, and applications of bio-succinic acid, such as plasticizers, polyurethanes and de-icing solutions. During 2011, the Company created a wholly owned subsidiary, BioAmber International, S.a.r.l.

The Company develops bio-succinic acid for a range of markets, such as personal care products and food additives, plasticizers, polyurethanes, resins and coatings. The applications for bio-succinic acid include plasticizers, polyurethanes, personal care products, de-icing solutions, resins and coatings, food additives, lubricants and other products. Plasticizers are organic esters that are primarily used to make flexible polyvinyl chloride. Adipic acid is used in polyester polyols, which are used to make polyurethanes. Polyurethanes are used in, among other things, soles for footwear, molded foams for automotive applications, such as car seats and arm rests, and non-foam applications such as coatings, adhesives and sealants. Other applications of bio-succinic acid that are developed and tested by potential customers, which include anti-freeze solutions, solvents, water treatment chemicals and effervescence agents such laundry tablets and bath salts.

The Company competes with Gadiv Petrochemical Industries ! Ltd., Mitsubishi Chemical, DSM, Anqing Hexing Chemical Co Ltd, Anhui Sunsing Chemicals Co., Ltd., Genomatica, Inc., Myriant Corporation and Roquette Freres S.A.

Advisors' Opinion:

• [By Markus Aarnio]

  BioAmber (BIOA) is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products.

• [By Maxx Chatsko]

  He believes several companies have set the bar precipitously low to start the year despite targeted developments expected to occur before the start of 2014. Watch the following video for his thoughts on potential positive surprises awaiting investors in�Amyris� (NASDAQ: AMRS  ) ,�BioAmber� (NYSE: BIOA  ) ,�Codexis� (NASDAQ: CDXS  ) , and�Solazyme� (NASDAQ: SZYM  ) .

• [By Matt Jarzemsky]

  Out of the 2013 vintage, some of the best performers so far this year have been early-stage healthcare firms like BioAmber Inc.(BIOA), up 86% year-to-date through Thursday, and Kindred Biosciences Inc.(KIN), up 82%. A number of high-flying tech startups have also continued to soar. Cybersecurity firm FireEye Inc.(FEYE) has gained 67% since the start of the year. Online coupon company RetailMeNot Inc.(SALE) is up 48%.

Best Warren Buffett Stocks To Own Right Now: ONYX Pharmaceuticals Inc.(ONXX)

Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. The company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., develops and markets Nexavar (sorafenib) tablet, a multiple kinase inhibitor for the treatment of liver cancer and advanced kidney cancer. It is also conducting Phase III clinical trial on Nexavar for the treatment of kidney, liver, lung, thyroid, breast, and non-small cell lung cancers; clinical trials on carfilzomib, a proteasome inhibitor for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors; and Phase Ib/II clinical trial on Oprozomib, an oral proteasome inhibitor. In addition, Onyx Pharmaceuticals, Inc. is developing ONX 0914, an immunoproteasome inhibitor, which is in preclinical stage for the treatment of autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease, and lupus. Further, the company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., is conducting clinical trials on Regorafenib, a multi-kinase inhibitor to treat metastatic colorectal cancer and gastrointestinal stromal tumors. It has a collaboration agreement with Warner-Lambert Company to discover and commercialize small molecule drugs that restore control of or intervene in the misregulated cell cycle in tumor cells. The company also has development and license agreements with BTG International Limited for the development and commercialization of ONX 0801, a novel targeted oncology compound; and Ono Pharmaceutical Co., Ltd. to develop and commercialize carfilzomib and Oprozomib for oncology indications in Japan. Onyx Pharmaceuticals, Inc. was founded in 1992 and is headquartered in South San Francisco, California.

Advisors' Opinion:

• [By Brian Orelli]

  AVEO's mistake seems to have been going head to head against the second-best drug for kidney cancer, Nexavar sold by Onyx Pharmaceuticals (NASDAQ: ONXX  ) and Bayer, rather than top-selling Sutent sold by Pfizer (NYSE: PFE  ) . While progression-free survival was longer for the group taking tivozanib, once patients progressed, they wanted another drug. Lots of patients taking Nexavar crossed over to take tivozanib. Essentially some patients got two drugs while other only got one, confounding the overall survival data.

• [By Sean Williams]

  Finally, off in its own world this week is Onyx Pharmaceuticals (NASDAQ: ONXX  ) , which purportedly has received a $130-per-share buyout offer, or $9.5 billion, from Amgen, as Reuters reported earlier this week. According to people familiar with the matter, Onyx is still exploring interest from other suitors, but it may be interested in accepting Amgen's offer, which is $10 a share higher than its original offer roughly six weeks ago. This news comes on the heels of Onyx's second-quarter results, which showed losses were halved to just $53 million and revenue more than doubled to $153 million. If Onyx accepts the deal at $130 per share, I'd suggest Amgen is still getting itself a decent bargain.

5 Best Transportation Stocks To Own For 2015: Lenovo Group Ltd (LNVGY)

Lenovo Group Limited (Lenovo) is a personal technology company serving customers in more than 160 countries. The Company is a personal computer (PC) vendor. The Company develops, manufactures and markets technology products and services. Its product lines include Think-branded commercial PCs and Idea branded consumer PCs, as well as servers, workstations, and a family of mobile Internet devices, including tablets and smart phones. Lenovo operates seven research and development centers and more than 46 world-class labs, including research centers in Yamato, Japan; Beijing, Shanghai and Shenzhen, China; and Raleigh, North Carolina, the United States. The Company is also engaged in investment holding. It operates in three segments: China, emerging markets (excluding China) and mature markets. Lenovo offers a range of commercial desktops to businesses of all sizes.

The Company�� products include laptops, tablets, desktops, workstations and servers. In May 2010, it launched the LePhone smartphone in China. During the fiscal year ended March 31, 2011 (fiscal 2011), China accounted for 46.4% of the Company�� total sales. During fiscal 2011, Emerging Markets (excluding China) accounted for 17.9% of the Company�� total sales. During fiscal 2011, Mature Markets accounted for 35.7% of the Company�� total sales. Its brands include ThinkPad notebook, as well as products carrying the ThinkCentre, ThinkStation, ThinkServer, IdeaCentre and IdeaPad sub-brands.

Advisors' Opinion:

• [By Eric Volkman]

  Alamy Late last month, Chinese hardware giant Lenovo (LNVGY) was the subject of many headlines -- not all of them complimentary -- when it signed a high-profile deal to buy the Motorola Mobility smartphone unit from Google (GOOG). The Asian firm is ponying up a cool $2.9 billion to acquire the business, which is monstrously unprofitable to the tune of a $645 million operating loss in the first nine months of 2013. The market didn't appreciate this. Disturbed by the idea of gallons of red ink spilling from Motorola Mobility onto Lenovo's results, investors traded down the firm's stock by as much as 14 percent after the deal was made public. This might have been compounded by the firm's previous announcement, made only days earlier, that it was spending $2.3 billion to purchase IBM's (IBM) x86 -- read: lower-end -- line of servers. Was such a sell-off, in reaction to either or both, justified? At Home Abroad Lenovo is one of those companies that likes to expand by acquisition. Few Westerners had ever heard of the IT manufacturer in 2005 when it closed its first big buy -- the personal computing division of IBM, for total consideration of around $1.75 billion. The purchase seemed a counterintuitive move when everyone knew that a future stuffed with wireless Internet and portable computing was just around the corner. But guess what? Lenovo not only sold plenty of notebooks and desktops, it managed to grow into the top PC manufacturer in the world. According to figures from Gartner (IT), in Q4 2013 the company was the clear market leader in terms of PC vendor unit shipments. It moved nearly 15 million PCs during the quarter, a figure 6.6 percent higher than in the same period the previous year. This was particularly impressive considering that total shipments for the industry dropped by almost 7 percent over that time frame. Lenovo was able to do this because, for most of its life, it's made big strides in less affluent markets and is continuing to do so. In

• [By vinaysingh]

  Apart from the above-mentioned business areas, HP's core competency still lies in PC markets and we are already aware of the smart devices wave that has almost swept the demand for desktops. In spite of battered demand in consumer PC market, HP increased the unit shipments by 6% y-o-y due to improved demand conditions in the commercial PC markets. As a result of a sturdy performance, HP's market share is now just slightly lower than that of Lenovo (LNVGY), the leader in the PC market. A report from Gartner showcases the shares of enterprises that occupy this market.

Best Warren Buffett Stocks To Own Right Now: Timmins Gold Corp (TGD)

Timmins Gold Corp. (Timmins) is a gold mining and exploration company. The Company is engaged in exploration, mine development and the mining and extraction of precious metals, primarily gold. Its primary asset and material mineral property is the San Francisco Gold Property located in Sonora, Mexico, which includes the Company�� only operating mine (the Mine). Its projects include El Capomo Property, Timm Property, El Picacho Property, Patricia and Norma Property, San Onesimo, Zindy and San Fernando Properties, Quila Property and Cocula Property. El Capomo Property is located in Nayarit State, approximately 50 kilometers east of Puerto Vallarta. It acquired Timm Property by staking a 45,000 hectare land package in the Penasquito area. Patricia and Norma Property consists of approximately 20,000 hectares were staked by the Company and are located in the Municipality of Trincheras, Sonora, Mexico. Its Cocula Property is located approximately 50 kilometers west of Guadalajara, Jalisco. Advisors' Opinion:

• [By Anthony Mirhaydari]

  I’ve added shares of BAA to my Edge Letter Sample Portfolio.

  Breakout Gold Stocks to Buy: Timmins Gold (TGD)

  
  Click to Enlarge Timmins Gold (TGD), like the other two gold stocks, is also challenging its 200-day moving average as buyers pour capital into a sector that had been left for dead. An upside breakout here would be the first since early 2013.

Best Warren Buffett Stocks To Own Right Now: Spectra Energy Partners LP(SEP)

Spectra Energy Partners, LP operates as an investment arm of Spectra Energy Corp. Spectra Energy Partners, LP, through its subsidiaries, engages in the transportation of natural gas through interstate pipeline systems, and the storage of natural gas in underground facilities in the United States. As of December 31, 2007, it owned and operated 100% of the approximately 1,400-mile East Tennessee interstate natural gas transportation system that extends from central Tennessee eastward into southwest Virginia and northern North Carolina, and southward into northern Georgia; and a liquefied natural gas storage facility in Kingsport, Tennessee with working gas storage capacity of approximately 1.1 billion cubic feet (Bcf) and re-gasification capability of 150 million cubic feet per day. The company also owned a 24.5% interest in the approximate 700-mile Gulfstream interstate natural gas transportation system, which extends from Pascagoula, Mississippi, and Mobile, Alabama across the Gulf of Mexico and into Florida; a 50% interest in Market Hub, which owns and operates 2 salt cavern natural gas storage facilities, the Egan storage facility with gas capacity of approximately 20 Bcf, and the Moss Bluff storage facility with working gas capacity of 15 Bcf. The company transports and stores natural gas for local gas distribution companies, municipal utilities, interstate and intrastate pipelines, direct industrial users, electric power generators, marketers, and producers. Spectra Energy Partners (DE) GP, LP, operates as the general partner to Spectra Energy Partners, LP. The company is based in Houston, Texas.

Advisors' Opinion:

• [By Rich Duprey]

  Natural gas transportation and storage master limited partnership�Spectra Energy Partners� (NYSE: SEP  ) �announced its 22d consecutive increase in its quarterly dividend payment. Spectra�will pay a�quarterly cash distribution�of $0.50125 on May 15 to the holders of record at the close of business on May 9. That's an increase of five-eighths cent over the previous level of�$0.495�per unit.

• [By Seth Jayson]

  Spectra Energy Partners (NYSE: SEP  ) reported earnings on May 3. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Spectra Energy Partners met expectations on revenues and beat expectations on earnings per share.